Unregistered Cannabis Products Fail to Meet TGA Requirements
Here’s how Australia could reap the benefits from a stricter regulatory cannabis framework

Unregistered Cannabis Products Fail to Meet TGA Requirements

Unregistered Cannabis Products Fail to Meet TGA Requirements 22nd September, 2020The TGA’s recent Laboratories Testing Report on routine surveillance of unregistered products supplied to the Australian market via the SAS…

Continue Reading Unregistered Cannabis Products Fail to Meet TGA Requirements
FreshLeaf Q3 Market Report Press Release
Our Q3 2020 report is FreshLeaf Analytics’ fifth market report on patients, products and pricing in the Australian market.

FreshLeaf Q3 Market Report Press Release

Australia’s Most Comprehensive Medicinal Cannabis Report: Q3 2020 Thursday 17 September 2020FreshLeaf Analytics is excited to release Australia’s most comprehensive medicinal cannabis Patient, Product and Pricing Analysis.Q3 was defined by…

Continue Reading FreshLeaf Q3 Market Report Press Release
ASX pot stocks are getting high after TGA interim ruling
FreshLeaf has access to full product details for most medicinal cannabis products available in the marketplace in Australia.

ASX pot stocks are getting high after TGA interim ruling

Stockhead Cannabis stocks were one of the rare groups in the green on a dismal day for the ASX on Wednesday following an interim ruling by the Therapeutic Goods Administration that could…

Continue Reading ASX pot stocks are getting high after TGA interim ruling
FreshLeaf Analytics S3
FreshLeaf also has exclusive access to significant datasets generated by some of Australia’s largest medicinal cannabis healthcare companies

FreshLeaf Analytics S3

FreshLeaf Analytics welcomes TGA interim decision on CBD down-scheduling September 9th 2020Therapeutic Goods Administration (TGA) sticks to their guns on initial proposal for over-the-Counter low-dose CBD but no smoking, vaping,…

Continue Reading FreshLeaf Analytics S3